The SEC61A1 gene helps move newly made proteins into the part of the cell that folds and sends them where they need to go. It also supports normal balance inside cells, including calcium handling. If this gene does not work properly, proteins can build up or be sent to the wrong place, which may lead to kidney disease, low antibody levels, and repeated infections in some people. Many variants in this gene have little effect, while a few change how well this transport system works.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SEC61A1Gene function
What if the gene works
The SEC61A1 gene helps form a channel in the endoplasmic reticulum, a cell compartment that processes proteins. This lets newly made proteins enter the right place for folding, quality control, and transport.
Risk
What if the gene does not work
Some variants in the SEC61A1 gene are linked to kidney tubule disease, while others can affect immune cell function and lower antibody levels, leading to repeated infections. Milder and more severe variants can influence which problems appear and how early.
Treatment
What does that mean for your treatment
No treatment or drug choice strategy specific to pathogenic variants in the SEC61A1 gene is currently established in clinical guidelines. In early research, the SEC61A1 gene and the SEC61 channel are being studied as possible drug targets, especially in cancer and immune signaling.
Gene function
What if the gene works
Your cells are constantly making proteins that need to reach the right place. The SEC61A1 gene helps form a tiny gateway in the cell's protein processing area so those proteins can enter or settle into a membrane. Understanding what the SEC61A1 gene does in the body helps explain how cells prepare and route many everyday proteins.
The SEC61A1 gene helps create a channel that lets newly made proteins move into the endoplasmic reticulum (the cell area that folds and prepares many proteins). This is an early step for proteins that will be released from the cell or sent to specific destinations.
Some proteins need to become part of a membrane instead of staying free inside the cell. Through its protein, the SEC61A1 gene helps guide these proteins into the membrane in the right orientation as they are made.
This channel sits next to ribosomes, the cell's protein making machines. That setup lets certain proteins enter the protein processing area while they are still being built.
By moving proteins into the right compartment, the SEC61A1 gene supports the cell's internal shipping pathway. This helps proteins continue on to folding, finishing steps, and delivery to the places where they work.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change a gene’s function to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SEC61A1 gene can alter the shape or stability of its channel protein, so proteins may enter the endoplasmic reticulum (the cell’s protein processing compartment) less efficiently. Some SEC61A1 gene variants mainly reduce channel activity, while more disruptive variants can cause misfolding, poor trafficking inside the cell, and ongoing cell stress. This helps explain how SEC61A1 variants affect protein transport, and why milder changes may be linked to later or milder features, while severe variants can bring earlier, broader effects.
How variants are linked to conditions
Pathogenic variants in the SEC61A1 gene cause a form of inherited kidney disease called autosomal dominant tubulointerstitial kidney disease, often written as ADTKD-SEC61A1. This SEC61A1 gene and kidney disease link is the best-established one, and affected people may develop slowly worsening kidney function, sometimes with anemia or other features that vary by family.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely seen across the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. In contrast, a single well-defined variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SEC61A1 gene. Risk appears to depend mainly on the specific gene change and the condition linked to it, so anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of SEC61A1 variants
For SEC61A1-related conditions, the inheritance pattern is usually autosomal dominant. This means a parent carrying a disease-causing variant in the SEC61A1 gene can pass it to a child of any sex, and each pregnancy has a 50% chance of inheriting that variant. In practical terms, the SEC61A1 inheritance pattern is the same for sons and daughters.
What does my SEC61A1 result mean for my family?
For SEC61A1, the family impact is usually thought of as dominant, which means close relatives like parents, brothers, sisters, and children may also carry the same gene change. If a SEC61A1 result is linked to a recognized SEC61A1-related condition, relatives may want to learn whether the variant is present in their branch of the family. The exact implications can vary a little depending on the specific condition and variant involved.
Genetic information
Genetic testing
How you find out about variants
SEC61A1 genetic testing looks for changes in the SEC61A1 gene using a blood sample, saliva sample, or cheek swab. A lab reads the DNA code of the gene and checks for variants that may help explain a person’s symptoms or show whether a variant is present in other family members.
When should I consider getting a genetic test?
SEC61A1 testing may be worth discussing if you or close relatives have unexplained long-term kidney disease, especially if it runs in the family. It can also be considered with repeated serious infections or low white blood cell counts or antibody levels. A result may help explain the cause and clarify risks for relatives.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but what it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. These common inherited differences can influence how well a medicine works and how likely side effects are.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body handles a drug and how strong its effects are. This understanding can support more informed, individualized treatment decisions. More information about this topic is available in the LearnHub.
Drugs influenced by the SEC61A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Across cultures and time periods, inherited patterns were noted, but the story of the SEC61A1 gene began in basic cell biology rather than public awareness. In the 1970s and 1980s, researchers studying how newly made proteins enter the cell’s internal transport system identified a key channel first in yeast, called Sec61. Soon after, scientists found the human counterpart and named it the SEC61A1 gene. From these first observations, research expanded steadily. Work on Sec61 proteins became part of the broader effort that clarified how cells move proteins to the right place, an important step in modern molecular medicine. More recently, rare disease studies linked variants in the SEC61A1 gene to human health conditions, bringing this long studied gene into clinical genetics.